These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 533262)
21. In vitro activity of amikacin and ten other aminoglycoside antibiotics against gentamicin-resistant bacterial strains. Reyonolds AV; Hamilton-Miller JM; Brumfitt W J Infect Dis; 1976 Nov; 134 SUPPL():S291-6. PubMed ID: 62815 [TBL] [Abstract][Full Text] [Related]
22. Fortimicins A and B, new aminoglycoside antibiotics. IV. In vitro study of fortimicin A compared with other aminoglycosides. Girolami RL; Stamm JM J Antibiot (Tokyo); 1977 Jul; 30(7):564-70. PubMed ID: 19409 [TBL] [Abstract][Full Text] [Related]
23. In vitro susceptibility of clinically important bacteria to amikacin: correlation of results of broth dilution and disk sensitivity tests and effect of medium composition. Linzenmeier G; Naumann P; Neussel H; Rosin H J Infect Dis; 1976 Nov; 134 SUPPL():S262-70. PubMed ID: 825584 [TBL] [Abstract][Full Text] [Related]
24. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy. Bovelacci A; Montini G; Ramacciotti PG Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413 [TBL] [Abstract][Full Text] [Related]
25. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides. Watanakunakorn C; Kauffman CA Infection; 1978; 6(3):111-5. PubMed ID: 98451 [TBL] [Abstract][Full Text] [Related]
26. In vitro aminoglycoside resistance of gram-negative bacilli and staphylococci isolated from blood in Sweden 1980-1984. Bengtsson S; Bernander S; Brorson JE; Dornbusch K; Forsgren A; Hallander H; Henning C; Holm S; Malmborg AS; Nilsson L Scand J Infect Dis; 1986; 18(3):257-63. PubMed ID: 3738436 [TBL] [Abstract][Full Text] [Related]
27. Frequency of resistance to kanamycin, tobramycin, netilmicin, and amikacin in gentamicin-resistant gram-negative bacteria. Seligman SJ Antimicrob Agents Chemother; 1978 Jan; 13(1):70-3. PubMed ID: 626492 [TBL] [Abstract][Full Text] [Related]
28. Comparative in vitro activity of netilmicin, amikacin, tobramycin and sisomicin against gentamicin highly-resistant enterobacteriaceae. Tselentis J; Legakis NJ; Nicolas KJ; Melissinos K; Papavassiliou J Chemotherapy; 1980; 26(6):409-17. PubMed ID: 7408554 [TBL] [Abstract][Full Text] [Related]
29. Control of emergence of multi-resistant gram-negative bacilli by exclusive use of amikacin. Ruiz-Palacios GM; Ponce de Leon S; Sifuentes J; Ponce de Leon S; Calva JJ; Huazano F; Ontiveros C; Ojeda F; Bobadilla M Am J Med; 1986 Jun; 80(6B):71-5. PubMed ID: 3089006 [TBL] [Abstract][Full Text] [Related]
30. Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin. Thornsberry C; Barry AL; Jones RN; Baker CN; Badal RE; Packer RR Antimicrob Agents Chemother; 1980 Aug; 18(2):338-45. PubMed ID: 7447410 [TBL] [Abstract][Full Text] [Related]
31. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to netilmicin and selected aminoglycoside antibiotics. Meyer RD; Draus LL; Pasieczinik KA Antimicrob Agents Chemother; 1976 Oct; 10(4):677-81. PubMed ID: 825036 [TBL] [Abstract][Full Text] [Related]
32. In vitro activity of sisomicin, an aminoglycoside antibiotic, against clinical isolates. Stewart D; Bodey GP J Antibiot (Tokyo); 1975 Feb; 28(2):149-55. PubMed ID: 234415 [TBL] [Abstract][Full Text] [Related]
34. In vitro activity of aminoglycosides against clinical isolates of Acinetobacter baumannii complex and other nonfermentative Gram-negative bacilli causing healthcare-associated bloodstream infections in Taiwan. Liu JY; Wang FD; Ho MW; Lee CH; Liu JW; Wang JT; Sheng WH; Hseuh PR; Chang SC J Microbiol Immunol Infect; 2016 Dec; 49(6):918-923. PubMed ID: 26364729 [TBL] [Abstract][Full Text] [Related]
35. In vitro activity of gentamicin, amikacin and netilmicin alone and in combination with carbenicillin against Serratia marcescens. Pogwizd SM; Lerner SA Antimicrob Agents Chemother; 1976 Dec; 10(6):878-84. PubMed ID: 795373 [TBL] [Abstract][Full Text] [Related]
36. Compound A49759, the 3-O-demethyl derivative of fortimicin A: in vitro comparison with six other aminoglycoside antibiotics. Jones RN; Thornsberry C; Barry AL; Packer RR; Baker CN; Badal RE Antimicrob Agents Chemother; 1980 Nov; 18(5):773-9. PubMed ID: 7447431 [TBL] [Abstract][Full Text] [Related]
37. A laboratory assessment of the activities of four aminoglycosides. Schrire L; Robinson RG; Koornhof HJ S Afr Med J; 1984 Jun; 65(23):922-4. PubMed ID: 6427946 [TBL] [Abstract][Full Text] [Related]
38. Effects of procedural variations on the activity of aminoglycosides in vitro. Sanders CC; Sanders WE Am J Clin Pathol; 1975 Mar; 63(3):438-45. PubMed ID: 1119441 [TBL] [Abstract][Full Text] [Related]
39. Comparative activity of netilmicin, gentamicin, amikacin, and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae. Briedis DJ; Robson HG Antimicrob Agents Chemother; 1976 Oct; 10(4):592-7. PubMed ID: 825032 [TBL] [Abstract][Full Text] [Related]
40. In vitro activity of netilmicin compared with gentamicin, tobramycin, amikacin, and kanamycin. Eickhoff TC; Ehret JM Antimicrob Agents Chemother; 1977 May; 11(5):791-6. PubMed ID: 879733 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]